Strides Pharma Inc.: Drug Recall
Recall #D-1330-2022 · 07/19/2022
Class II: Risk
Recall Details
- Recall Number
- D-1330-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Strides Pharma Inc.
- Status
- Terminated
- Date Initiated
- 07/19/2022
- Location
- East Brunswick, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1032 bottles
Reason for Recall
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Product Description
Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.
Distribution Pattern
US Nationwide
Other Recalls by Strides Pharma Inc.
- Class II: Risk 07/09/2025
- Class II: Risk 03/05/2025
- Class II: Risk 03/05/2025
- Class II: Risk 12/29/2023
- Class II: Risk 06/26/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.